ETFs most similar to HELX
The funds whose holdings overlap Franklin Genomic Advancements ETF the most, by weight. as of Jun 30, 2026SEC filing
By holdings overlap
| Fund | Category | Overlap with HELX | Fee | Assets | 1Y | Yield | Compare |
|---|---|---|---|---|---|---|---|
| HELXFranklin Genomic Advancements ETF | Biotech & Health Innovation | — | 0.50% | $32M | +29.2% | 0.34% | |
| WDNAWisdomTree BioRevolution Fund | Biotech & Health Innovation | 33% | 0.45% | $4.7M | +34.4% | 3.28% | side by side |
| HTECROBO Global Healthcare Technology and Innovation ETF | Biotech & Health Innovation | 27% | 0.68% | $74M | +33.4% | 0.81% | side by side |
| GNOMGlobal X Genomics & Biotechnology ETF | Biotech & Health Innovation | 26% | 0.50% | $101M | +63.4% | 0.94% | side by side |
| IBBiShares Biotechnology ETF | Biotech & Health Innovation | 26% | 0.44% | $10.8B | +35.9% | 0.17% | side by side |
| XBIState Street SPDR S&P Biotech ETF | Biotech & Health Innovation | 26% | 0.35% | $9.9B | +45.8% | 0.35% | side by side |
Overlap is the sum of the smaller of the two weights across every shared holding. Try any combination in the overlap tool.
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.